Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.63 CAD | -1.56% | -1.56% | -47.50% |
Apr. 08 | FSD Pharma Receives Nasdaq Non-Compliance Notice | MT |
Mar. 29 | FSD Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | - | Sales 2023 | - | Capitalization | 35.64M 26M |
---|---|---|---|---|---|
Net income 2022 | -23M -16.78M | Net income 2023 | -17M -12.4M | EV / Sales 2022 | - |
Net cash position 2022 | 16.46M 12.01M | Net cash position 2023 | 3.17M 2.32M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.26
x | P/E ratio 2023 |
-2
x | Employees | 17 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 82.63% |
1 day | -1.56% | ||
1 week | -8.70% | ||
Current month | -34.38% | ||
1 month | -31.52% | ||
3 months | -44.25% | ||
6 months | -56.85% | ||
Current year | -47.50% |
Managers | Title | Age | Since |
---|---|---|---|
Zeeshan Saeed
CEO | Chief Executive Officer | 54 | 94-10-19 |
Anthony Durkacz
FOU | Founder | 47 | 94-10-19 |
Nathan Coyle
DFI | Director of Finance/CFO | 43 | 19-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anthony Durkacz
FOU | Founder | 47 | 94-10-19 |
Donal Carroll
COO | Chief Operating Officer | 48 | 18-06-30 |
Lakshmi Kotra
BRD | Director/Board Member | 53 | 22-11-24 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 0.63 | -1.56% | 67,620 |
24-04-23 | 0.64 | 0.00% | 14,210 |
24-04-22 | 0.64 | +1.59% | 45,171 |
24-04-19 | 0.63 | -1.56% | 46,898 |
24-04-18 | 0.64 | 0.00% | 14,687 |
Delayed Quote Canadian Securities Exchange, April 24, 2024 at 02:49 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-47.50% | 18.78M | |
-1.51% | 105B | |
+3.22% | 97.5B | |
+1.86% | 22.19B | |
-16.53% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-20.09% | 14.52B | |
+5.47% | 14.09B | |
+28.85% | 10.99B |
- Stock Market
- Equities
- HUGE Stock